Ledger.Open graph →
SEC Form D · filed April 16, 2018

New Leaf Biopharma Opportunities II, L.P

Offering
$200.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
NEW YORK, NY
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Vijay O. Lathi · New York, NYExecLiam O. Ratcliffe · New York, NYExecRonald M. Hunt · New York, NYExecIsaac A. Manke · New York, NYExecNew Leaf Bpo Management Ii, L.L.C · New York, NYDirectorVijay O. Lathi · New York, NYExecFraser Bullock · LEHI, UTExecWooiyi Yin · Chamblee, GAExecBrandon Henderson · Chamblee, GAExecNew Leaf Bpo Associates Ii, L.P · New York, NYDirectorLuke Sorenson · LEHI, UTExecTim Layton · LEHI, UTExecAdam Boyden · San Francisco, CAExecAnthony Pompliano · San Francisco, CAExecNew Leaf Bpo Associates Ii, L.P · New York, NYDirectorNew Leaf Bpo Management Ii, L.L.C · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗